The Patent Finder

Avanir Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Avanir Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Back to Avanir Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 7,659,282Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
Term ended
Term ended Nov 10, 2025 · From the USPTO record
Term endedTerm ended Nov 10, 2025From the USPTO record
US 8,227,484Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
Term ended
Ended no later than Jul 17, 2023 · From the USPTO record
Term endedEnded no later than Jul 17, 2023From the USPTO record
US 6,207,674Dextromethorphan and oxidase inhibitor for weaning patients from narcotics and anti-depressants
Term ended
Term ended Dec 22, 2019 · From the USPTO record
Term endedTerm ended Dec 22, 2019From the USPTO record
US 6,440,980Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
Term ended
Ended no later than Aug 22, 2017 · From the USPTO record
Term endedEnded no later than Aug 22, 2017From the USPTO record
US 6,829,455Driving Force Transmission Mechanism, Image Forming Apparatus Equipped with Such a Mechanism, and Process Unit of Such an Apparatus
Formerly held
Lapsed on the fee record
Ended Dec 7, 2016 · High confidence
Lapsed on the fee recordEnded Dec 7, 2016High confidence
US 7,442,373Antibodies against protective antigen and methods of use for passive immunization and treatment of anthrax
Formerly held
Lapsed on the fee record
Ended Oct 28, 2016 · From the USPTO record
Lapsed on the fee recordEnded Oct 28, 2016From the USPTO record
US 7,438,909Immunization and treatment methods for anthrax
Formerly held
Lapsed on the fee record
Ended Oct 21, 2016 · From the USPTO record
Lapsed on the fee recordEnded Oct 21, 2016From the USPTO record
US RE38,115Dextromethorphan and an oxidase inhibitor for treating intractable conditions
Term ended
Term ended Sep 19, 2016 · From the USPTO record
Term endedTerm ended Sep 19, 2016From the USPTO record
US 7,235,565Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
Lapsed on the fee record
Ended Jun 26, 2015 · From the USPTO record
Lapsed on the fee recordEnded Jun 26, 2015From the USPTO record
US 7,230,106Process for the preparation of inhibitors of macrophage migration inhibitory factor
Lapsed on the fee record
Ended Jun 12, 2015 · From the USPTO record
Lapsed on the fee recordEnded Jun 12, 2015From the USPTO record
10 of 53 patents shown.
Pro members see all 53.
Pro members: see all 53 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited